Announcing our latest investment led by Spectrum Equity and McKesson Ventures
RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture Partners, and dRx Capital. RxVantage’s goal is to promote technology...